squamous-cell-carcinoma

Documents about squamous-cell-carcinoma

• Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma#825031ClinicalTrials.gov
• Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and Epacadostat#861869ClinicalTrials.gov
• Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma#894205ClinicalTrials.gov
• Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery#881524ClinicalTrials.gov
• Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer#837526ClinicalTrials.gov
• Concurrent Chemoradiotherapy for Stage IVB Esophageal Squamous Cell Carcinoma（EC-CRT-003）#272337ClinicalTrials.gov
• Oral Cavity Squamous Cell Carcinoma and Readmission: Rates, Causes, and Risk Factors.#802358ClinicalTrials.gov
• Effect of Accelerated RTH in Squamous Cell Carcinoma in Head and Neck#835535ClinicalTrials.gov
• NeoAdjuvant Therapy With Immunoreagent (SHR-1316) for Resectable Oesophageal Squamous Cell carciNoma#849226ClinicalTrials.gov
• Study of MRI Guided Personal Chemoradiotherapy and Immunotherapy for Limited Advanced Esophageal Squamous Caicinoma.#136312ClinicalTrials.gov
• Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma#158108ClinicalTrials.gov
• Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer#859399ClinicalTrials.gov
• Personalised Immunotherapy Platform#407714ClinicalTrials.gov
• Time Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC) or Unresectable or Metastatic Renal Cell Carcinoma (RCC)#651251ClinicalTrials.gov
• Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer#873612ClinicalTrials.gov
• Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer#810269ClinicalTrials.gov
• Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy#893493ClinicalTrials.gov
• A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.#143579ClinicalTrials.gov
• Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma#208457ClinicalTrials.gov
• Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma#230410ClinicalTrials.gov
• Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma#283023ClinicalTrials.gov
• Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"#874543ClinicalTrials.gov
• A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma.#882893ClinicalTrials.gov
• INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma#290996ClinicalTrials.gov
• Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma#848947ClinicalTrials.gov
• Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery#230429ClinicalTrials.gov
• Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma#387157ClinicalTrials.gov
• Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma#870888ClinicalTrials.gov
• Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Study.#886257ClinicalTrials.gov
• Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell Cancer#256878ClinicalTrials.gov
• Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck#892819ClinicalTrials.gov
• Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung#860438ClinicalTrials.gov
• Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer Survivors#853847ClinicalTrials.gov
• Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck#887235ClinicalTrials.gov
• Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma#383565ClinicalTrials.gov
• Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CRIS-2 Trial）#424180ClinicalTrials.gov
• Lung-MAP S1400K: c-MET Positive#444873ClinicalTrials.gov
• Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma#836192ClinicalTrials.gov
• Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus#837008ClinicalTrials.gov
• XH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell Carcinoma#839764ClinicalTrials.gov
• A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors#332738ClinicalTrials.gov
• Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy#837046ClinicalTrials.gov
• Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma#861703ClinicalTrials.gov
• Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck#878842ClinicalTrials.gov
• Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinomas#201783ClinicalTrials.gov
• Multi-omics Monitoring of Dynamic Evolution in Esophageal Squamous Cell Carcinoma: PKU-ESCC-Monitor#18580ClinicalTrials.gov
• Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma#195300ClinicalTrials.gov
• A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)#329525ClinicalTrials.gov
• Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery#373603ClinicalTrials.gov
• Thermotherapy in Addition to SOC Palliative Radiotherapy#398320ClinicalTrials.gov